Videos

Joe Moose, owner of Moose Professional Pharmacy, discusses how the roles of pharmacy technicians have changed.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses methods specialty pharmacies can use to help patients access high cost medications.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses how the movement toward value-based care has changed independent pharmacists' business goals.

Jerry McKee, PharmD, assistant director of Community Care of North Carolina, discusses the goals of the Pharmacy Home Project.

Jerry McKee, PharmD, assistant director of Community Care of North Carolina, discusses his organization's mission.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses the technology trends that independent pharmacists should endeavor to familiarize themselves with.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses the challenges independent pharmacists face with respect to customer retention efforts.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how specialty pharmacies can leverage technology to improve the consumer experience.

This weekly video program highlights the latest in pharmacy news, product news, and more.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses the benefits of MedImpact's iRx program.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the implications of rising drug costs on specialty pharmacy.

This weekly video program highlights the latest in pharmacy news, product news, and more.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the relationship between specialty pharmacies and accountable care organizations.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the potential of biosimilars to reduce the cost burden of specialty pharmaceuticals.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses how specialty pharmacies can enhance their operations with data analytics.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

David Lassen, chief clinical officer at Prime Therapeutics, discusses important developments in specialty pharmacy.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses what comprises an effective pharmacy accreditation program.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Marc O'Connor, chief operating officer of Curant Health, discusses potential changes patients of specialty pharmacies may experience in the near future.

David Lassen, chief clinical officer at Prime Therapeutics, discusses how high cost hepatitis C drugs have impacted the entire specialty landscape.

This weekly video program highlights the latest in pharmacy news, product news, and more.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses methods to improve communication among drug manufacturers and health care providers.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses the role of the pharmacist in acute coronary syndrome management with platelet aggregation inhibitors.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC discusses the use of technology to optimize clinical services in specialty pharmacy.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how platelet aggregation inhibitors fit into the acute coronary syndrome management picture.